// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























169 Abstracts

Serum Cystatin C is an Alternative Measure of Renal Function and is Superior to Serum Creatinine for Prediction of Adverse Events in Left Ventricular Assist Device Patients

Alberto Pinsino - American Heart Association (AHA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

The Ratio Serum Creatinine/Serum Cystatin C as a Predictor of Ischemic Risk in Elderly Patients With Coronary Artery Disease

Hak Seung Lee - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Hypertensive Diseases in Pregnancy and Renal Function Later in Life: Insights From the Genetic Epidemiology Network of Arteriopathy Study

Adebamike A Oshunbade - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

KIDNEY INJURY, VASCULAR REACTIVITY AND STIFFNESS IN GENDER SUBGROUPS OF HYPERTENSIVE PATIENTS

Mironova, S - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

BIOMARKERS OF KIDNEY INJURY IN GENDER SUBGROUPS OF HYPERTENSIVE PATIENTS

Mironova, S - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

INTERCONNECTION BETWEEN RENAL FILTRATION FUNCTION AND GENE POLYMORPHISM IN PATIENTS WITH ARTERIAL HYPERTENSION

Koziolova, N - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

IMPACT OF AGGRESSIVE BLOOD PRESSURE REDUCTION ON KIDNEY FUNCTION AFTER RENAL DENERVATION ( LONG-TERM OUTCOMES )

Mironova, S - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Resistant hypertension

N/A

Role of cardiac troponin T in predicting development of acute kidney injury following liver transplantation

H. Kamei - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

Cystatin C for Estimation of Renal Function and Valganciclovir Dosing in Heart Transplant Patients

Alberto Pinsino - Heart Failure Society of America (HFSA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

TA-9070

Genetic variations in Amyloid-beta1-42 clearance proteins determine onset of dementia in Parkinson’s disease and dementia with Lewy bodies

K. Brockmann - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Lewy body dementia

N/A

Cystatin C- versus Creatinine- Based Assessment of Renal Function in Patients Admitted With Heart Failure: Insights From DOSE, ROSE and CARRESS-HF

Yu Chiang Wang - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Neutrophil‐Gelatinase‐Associated Lipocalin and Cystatin C Predict Acute Kidney Injury Progression and Transition to Chronic Kidney Disease in Critically Ill Cirrhotics

Rakhi Maiwall - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

N/A

Biochemical differences in patients with COPD due to tobacco and COPD by Biomass hospitalized in the intensive care unit

Marcos Alejandro Escobar Penagos - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Ischemic stroke

N/A

BAY 94-9027 Provides Safe and Effective Long-Term Prophylaxis in Pediatric Patients: Results from the PROTECT VIII Kids Extension Study

Sanjay Ahuja - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute renal failure

Recombinant Factor VIII

Assessment of Estimated Glomerular Filtration Rate in a Cohort of 1200 Cancer Patients Using Serum Creatinine and Cystatin C

Costa e Silva Veronica�Torres - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Efficacy Evaluation of Neutrophil Gelatinase-Associated Lipocalin and Cystatin C in Urine as Biomarkers in Early Diagnosis of AKI in Preterm

Li Dong - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

A Case of AKI Secondary to Niraparib, a Poly ADP Ribose Polymerase Inhibitor

Ravipati KrishnaS - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Dyslipidemia

Niraparib

Cystatin C Use in Clinical Practice

Torres Jennifer - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of Mortality Risk Across Deciles of Cystatin C and Creatinine Among US Veterans

Wenziger Cachet - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Using the Difference in Estimated Glomerular Filtration Rate by Cystatin C vs. by Serum Creatinine (eGFRDiff) to Assess Muscle Mass and Frailty in Older Adults

Potok O. Alison - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Leukodystrophy, hypomyelinating, 6

N/A

Copyright © 2026. QuantiNova All rights reserved